Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:4.1.1.32 (phosphoenolpyruvate carboxykinase)
 4,204 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Regulation of expression of the phosphoenolpyruvate carboxykinase (PEPCK) gene was examined in an adult rat hepatocyte line, RALA255-10G, that was immortalized with an SV40 temperature-sensitive (ts) A mutant. These hepatocytes express a transformed phenotype at the permissive temperature (33 degrees C) but a differentiated liver phenotype at the nonpermissive temperature (40 degrees C). We have shown previously that RALA255-10G cells express only low levels of liver-specific genes such as albumin and tyrosine aminotransferase at 33 degrees C. In the present study, we demonstrated that at 33 degrees C, PEPCK synthesis and mRNA expression could be detected only in the simultaneous presence of dexamethasone (DEX), retinoic acid, and dibutyryl-cAMP (Bt2cAMP). At 40 degrees C, PEPCK synthesis and mRNA expression were demonstrated in the presence of Bt2cAMP alone, but not in the presence of either DEX or retinoic acid. However, at 40 degrees C, PEPCK gene expression was stimulated by the combination of DEX plus retinoic acid; additionally, DEX and retinoic acid potentiated the Bt2cAMP-mediated PEPCK induction. In RALA255-10G cells, optimal PEPCK gene expression required the simultaneous presence of DEX, retinoic acid, and Bt2cAMP; DEX had to be present at all times. Triiodothyronine (T3) also potentiated the Bt2cAMP-mediated PEPCK gene expression but failed to increase further the induction by DEX/retinoic acid/Bt2cAMP. By performing nuclear runoff assays, we demonstrated that the PEPCK gene transcription rate in the absence or presence of inducing agents was closely related to the levels of the corresponding mRNAs.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Induction of phosphoenolpyruvate carboxykinase gene expression by retinoic acid in an adult rat hepatocyte line. 217 87

In cultured adipose tissue of suckling rats, glucose alone is able to induce the appearance of fatty-acid synthase and acetyl-CoA carboxylase mRNA by a mechanism involving glucose-6-phosphate accumulation; insulin alone has no effect but potentiates the effect of glucose. In the present study, we have analysed in cultured adipose tissue the effects of other hormones on the expression of these enzymes as well as on phosphoenolpyruvate carboxykinase. Triiodothyronine has only a marginal effect on fatty-acid synthase expression, in the absence or presence of glucose and insulin. A synthetic glucocorticoid, dexamethasone, opposes the inductive effect of glucose and insulin on fatty-acid synthase expression but increases the expression of phosphoenolpyruvate carboxykinase. A beta-agonist, isoproterenol totally inhibits the inductive effect of glucose and insulin on acetyl-CoA carboxylase and fatty-acid synthase expression whereas it increases the expression of phosphoenolpyruvate carboxykinase. Similarly, glucagon and cAMP have antagonistic effects on glucose and insulin-induced fatty-acid synthase expression. These inhibitory effects cannot be explained only by a reduction in glucose-6-phosphate concentration. We conclude that, in adipose tissue, dexamethasone and cAMP-generating hormones are negative regulators of lipogenic enzyme expression. Finally, the regulation of phosphoenolpyruvate carboxykinase expression in adipose tissue is similar to that found in the liver, i.e. inhibition by insulin and glucose and activation by glucocorticoids and cAMP.
 ...
PMID:Regulation of lipogenic enzyme and phosphoenolpyruvate carboxykinase gene expression in cultured white adipose tissue. Glucose and insulin effects are antagonized by cAMP. 791 89

Triiodothyronine (T3) treatment of pregnant rats for 6 days, 10 micrograms/100 g, resulted in a pronounced induction of enzymes related to gluconeogenesis and lipogenesis and of mitochondrial FAD-glycerophosphate dehydrogenase in the maternal liver, as previously observed in male rats. There was virtually no change in the activity of these enzymes in the placenta. However, there was a distinct induction of these enzymes in the fetal liver, even if increments in fetal serum and liver T3 were much smaller than on the maternal side. This indicates that changes in hepatic enzyme activities are a more sensitive index of fetal hyperthyroidism than T3 levels. The increased lipogenic capacity was expressed by greater incorporation of a tritium tracer into fatty acids. Administration of triamcinolone, 2 mg/100 g, for the last 5 days of gestation resulted in marked induction of maternal hepatic enzymes of lipogenesis, gluconeogenesis and of aspartate aminotransferase (ASAT), known to occur in male rats, as well as in a metabolic pattern of insulin resistance. The response of placental enzymes was limited to a small elevation in ASAT and phosphoenolpyruvate carboxykinase (PEPCK) activity. In the fetal liver there was no stimulation of lipogenic enzymes, but a marked induction of PEPCK and ASAT. The changes in the lipogenic capacity were confirmed by tritium incorporation into serum and liver fatty acids. These results demonstrate the marked sensitivity of specific fetal enzyme systems to the maternal iatrogenic hyperthyroidism or hypercorticism. The limited alterations in placental enzyme activities are in accord with the concept that placental metabolic stability fulfils a protective function toward the fetus.
 ...
PMID:Modulation of fetal and placental metabolic pathways in response to maternal thyroid and glucocorticoid hormone excess. 813 95